Nimodipine protects dopaminergic neurons against inflammation-mediated degeneration through inhibition of microglial activation

Neuropharmacology

Volumn 56, Issue 3, 2009, Pages 580-589

  Li, Yachen ^a,b   Hu, Xiaoming ^b   Liu, Yuxin ^b   Bao, Yongming ^a   An, Lijia ^a  

^a DALIAN UNIVERSITY OF TECHNOLOGY   (China)

^b NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

Author keywords

LPS; Microglia; NADPH oxidase; Neurodegeneration; Neuroinflammation; Nimodipine

Indexed keywords

1 METHYL 4 PHENYLPYRIDINIUM; CALCIUM CHANNEL BLOCKING AGENT; INTERLEUKIN 1BETA; LIPOPOLYSACCHARIDE; NIMODIPINE; NITRIC OXIDE; PROSTAGLANDIN E2; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; SUPEROXIDE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DOPAMINERGIC NERVE CELL; DOSE RESPONSE; INFLAMMATION; INHIBITION KINETICS; MESENCEPHALON; MICROGLIA; MOUSE; NERVE DEGENERATION; NEUROPROTECTION; NONHUMAN; OXIDATIVE STRESS; PARKINSON DISEASE; PRIORITY JOURNAL; RAT;

ANIMALS; CELL CULTURE TECHNIQUES; DOPAMINE; INFLAMMATION; LIPOPOLYSACCHARIDES; MICE; MICROGLIA; NADPH OXIDASE; NERVE DEGENERATION; NEURONS; NIMODIPINE; OXIDATIVE STRESS; RATS;

EID: 58749084091     PISSN: 00283908     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuropharm.2008.10.016     Document Type: Article

References (51)

1. Aloisi F. The role of microglia and astrocytes in CNS immune surveillance and immunopathology. Adv. Exp. Med. Biol. 468 (1999) 123-133
2. Block M.L., and Hong J.S. Microglia and inflammation-mediated neurodegeneration: multiple triggers with a common mechanism. Prog. Neurobiol. 76 (2005) 77-98
3. Buttini M., Limonta S., and Boddeke H.W. Peripheral administration of lipopolysaccharide induces activation of microglial cells in rat brain. Neurochem. Int. 29 (1996) 25-35
4. Castaño A., Herrera A.J., Cano J., and Machado A. Lipopolysaccharide intranigral injection induces inflammatory reaction and damage in nigrostriatal dopaminergic system. J. Neurochem. 70 (1998) 1584-1592
5. Chao C.C., Molitor T.W., and Hu S. Neuroprotective role of IL-4 against activated microglia. J. Immunol. 151 (1993) 1473-1481
6. Cheepsunthorn P., Radov L., Menzies S., Reid J., and Connor J.R. Characterization of a novel brain-derived microglial cell line isolated from neonatal rat brain. Glia 35 (2001) 53-62
7. + channels. Am. J. Physiol. 266 (1994) C1650-C1655
8. Dickson D.W., Lee S.C., Mattiace L.A., Yen S.H., and Brosnan C. Microglia and cytokines in neurological disease: with special reference to AIDS and Alzheimer's disease. Glia 7 (1993) 75-83
9. Eder C. Ion channels in microglia (brain macrophages). Am. J. Physiol. Cell Physiol. 275 (1998) 327-342
10. Facchinetti F., Fasolato C., Del Giudice E., Burgo A., Furegato S., Fusco M., Basso E., Seraglia R., D'Arrigo A., and Leon A. Nimodipine selectively stimulated β-amyloid 1-42 secretion by a mechanism independent of calcium influx blockage. Neurobiol. Aging 27 (2006) 218-227
11. Färber K., and Kettenmann H. Functional role of calcium signals for microglial function. Glia 54 (2006) 656-665
12. Floyd R.A. Neuroinflammatory processes are important in neurodegenerative diseases: a hypothesis to explain the increased formation of reactive oxygen and nitrogen species as major factors involved in neurodegenerative disease development. Free Radic. Biol. Med. 26 (1999) 1346-1355
13. Fritze J., and Walden J. Clinical findings with nimodipine in dementia: test of the calcium hypothesis. J. Neural Transm. Suppl. 46 (1995) 439-453
14. Gao H.M., Jiang J., Wilson B., Zhang W., Hong J.S., and Liu B. Microglial activation-mediated delayed and progressive degeneration of rat nigral dopaminergic neurons: relevance to Parkinson's disease. J. Neurochem. 81 (2002) 1285-1297
15. Gayle D.A., Ling Z., Tong C., Landers T., Lipton J.W., and Carvey P.M. Lipopolysaccharide (LPS)-induced dopamine cell loss in culture: roles of tumor necrosis factor-α, interleukin-1β and nitric oxide. Brain Res. Dev. Brain Res. 133 (2002) 27-35
16. 2+ in microglia activated by prion protein fragment. Glia 21 (1997) 253-257
17. Horn J., de Haan R.J., Vermeulen M., Luiten P.G., and Limburg M. Nimodipine in animal model experiments of focal cerebral ischemia: a systematic review. Stroke 32 (2001) 2433-2438
18. Janis R.A., Silver P.J., and Triggle D.J. Drug action and cellular calcium regulation. Adv. Drug Res. 16 (1987) 309-591
19. Jeohn G.H., Kong L.Y., Wilson B., Hudson P., and Hong J.S. Synergistic neurotoxic effects of combined treatments with cytokines in murine primary mixed neuron/glia cultures. J. Neuroimmunol. 85 (1998) 1-10
20. Kreutzberg G.W. Microglia: a sensor for pathological events in the CNS. Trends Neurosci. 19 (1996) 312-318
21. Langley M.S., and Sorkin E.M. Nimodipine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in cerebrovascular disease. Drugs 37 (1989) 669-699
22. Lee S.C., Liu W., Dickson D.W., Brosnan C.F., and Berman J.W. Cytokine production by human fetal microglia and astrocytes. Differential induction by lipopolysaccharide and IL-1 beta. J. Immunol. 150 (1993) 2659-2667
23. Ling Z., Zhu Y., Tong C.W., Snyder J.A., Lipton J.W., and Carvey P.M. Progressive dopamine neuron loss following supra-nigral lipopolysaccharide (LPS) infusion into rats exposed to LPS prenatally. Exp. Neurol 199 2 (2006) 499-512
24. Liu B., and Hong J.S. Role of microglia in inflammation-mediated neurodegenerative diseases: mechanisms and strategies for therapeutic intervention. J. Pharmacol. Exp. Ther. 304 (2003) 1-7
25. Liu B., Du L., and Hong J.S. Naloxone protects rat dopaminergic neurons against inflammatory damage through inhibition of microglia activation and superoxide generation. J. Pharmacol. Exp. Ther. 293 (2000) 607-617
26. Liu B., Gao H.M., Wang J.Y., Jeohn G.H., Cooper C.L., and Hong J.S. Role of nitric oxide in inflammation-mediated neurodegeneration. Ann. N. Y. Acad. Sci. 962 (2002) 318-331
27. Mahe Y., Wakasugi H., Scamps C., Chouaib S., and Tursz T. Role of calcium on interleukin-1 production by monocytes: its relevance during T cell proliferation. Lymphokine Cytokine Res. 10 (1991) 165-172
28. McGeer P.L., and McGeer E.G. The inflammatory response system of brain: implications for therapy of Alzheimer and other neurodegenerative diseases. Brain Res. Brain Res. Rev. 21 (1995) 195-218
29. McGeer P.L., Yasojima K., and McGeer E.G. Inflammation in Parkinson's disease. Adv. Neurol. 86 (2001) 83-89
30. McGuire S.O., Ling Z.D., Lipton J.W., Sortwell C.E., Collier T.J., and Carvey P.M. Tumor necrosis factor alpha is toxic to embryonic mesencephalic dopamine neurons. Exp. Neurol. 169 (2001) 219-230
31. 2+ in human microglia. Neuroscience 91 (1999) 343-352
32. Meyer F.B., Tally P.W., Anderson R.E., Sundt Jr. T.M., Yaksh T.L., and Sharbrough F.W. Inhibition of electrically induced seizures by a dihydropyridine calcium channel blocker. Brain Res. 384 (1986) 180-183
33. Murray G.D., Teasdale G.M., and Schmitz H. Nimodipine in traumatic subarachnoid haemorrhage: a re-analysis of the HIT I and HIT II trial. Acta Neurochir. 138 (1996) 1163-1167
34. Möller T. Calcium signaling in microglial cells. Glia 40 (2002) 184-194
35. Nakajima K., and Kohsaka S. Microglia: activation and their significance in the central nervous system. J. Biochem. 130 (2001) 169-175
36. Nakamura Y. Regulating factors for microglial activation. Biol. Pharm. Bull. 25 (2002) 945-953
37. Ng Y.K., and Ling E.A. Induction of major histocompatibility class II antigen on microglial cells in postnatal and adult rats following intraperitoneal injections of lipopolysaccharide. Neurosci. Res. 28 (1997) 111-118
38. Nguyen M.D., Julien J.-P., and Rivest S. Innate immunity: the missing link in neuroprotection and neurodegeneration?. Nat. Rev. Neurosci. 3 (2002) 216-227
39. 3H-nimodipine in human brain. J. Neurosurg. 59 (1983) 933-937
40. Peskin A.V., and Winterbourn C.C. A microtiter plate assay for superoxide dismutase using a water-soluble tetrazolium salt (WST-1). Clin. Chim. Acta 293 (2000) 157-166
41. Qian L., Block M.L., Wei S.J., Lin C.F., Reece J., Pang H., Wilson B., Hong J.S., and Flood P.M. Interleukin-10 protects lipopolysaccharide induced neurotoxicity in primary midbrain cultures by inhibiting the function of NADPH oxidase. J. Pharmacol. Exp. Ther. 319 (2006) 44-52
42. Qian L., Tan K.S., Wei S.J., Wu H.M., Xu Z.l., Wilson B., Lu R.B., Hong J.S., and Flood P.M. Microglia-mediated neurotoxicity is inhibited by morphine through an opioid receptor-independent reduction of NADPH oxidase activity. J. Immunol. 179 (2007) 1198-1209
43. Qin L., Liu Y., Wang T., Wei S.J., Block M.L., Wilson B., Liu B., and Hong J.S. NADPH oxidase mediates lipopolysaccharide-induced neurotoxicity and proinflammatory gene expression in activated microglia. J. Biol. Chem. 279 (2004) 1415-1421
44. Sandin M., Jasmin S., and Levere T.E. Aging and cognition: facilitation of recent memory in aged nonhuman primates by nimodipine. Neurobiol. Aging 11 (1990) 573-575
45. Sawada M., Kondo N., Suzumura A., and Marunouchi T. Production of tumor necrosis factor-α by microglia and astrocytes in culture. Brain Res. 491 (1989) 394-397
46. Scriabine A., Schuurman T., and Traber J. Pharmacological basis for the use of nimodipine in central nervous system disorders. FASEB J 3 (1989) 1799-1806
47. Streit W.J., Graeber M.B., and Kreutzberg G.W. Functional plasticity of microglia: a review. Glia 1 (1993) 301-307
48. Szabó C., Thiemermann C., and Vane J.R. Dihydropyridine antagonists and agonists of calcium channels inhibit the induction of nitric oxide synthase by endotoxin in cultured macrophages. Biochem. Biophys. Res. Commun. 196 (1993) 825-830
49. Vergouwen M.D., Vermeulen M., and Roos Y.B. Effect of nimodipine on outcome in patients with traumatic subarachnoid haemorrhage: a systematic review. Lancet Neurol. 12 (2006) 1029-1032
50. 2+ channel blockers attenuate beta-amyloid peptide toxicity to cortical neurons in culture. J. Neurochem. 62 (1994) 372-375
51. Xie Z., Wei M., Morgan T.E., Fabrizio P., Han D., Finch C.E., and Longo V.D. Peroxynitrite mediates neurotoxicity of amyloid β-peptide1-42- and lipopolysaccharide-activated microglia. J. Neurosci. 22 (2002) 3484-3492